First generics and authorized generics may look the same, but their timing and origin change everything. Learn how brand companies use authorized generics to undercut independent generic manufacturers and limit price savings.
The FDA monitors generic drugs after approval using real-world data, adverse event reports, and inspections to ensure ongoing safety. Learn how systems like FAERS and Sentinel catch hidden risks that clinical trials miss.
The FDA removed the mandatory REMS program for clozapine in February 2025, but ANC monitoring remains essential. Learn how safety practices have changed and what patients and providers need to know now.
Learn the real risks of epidural and spinal procedures while on blood thinners, including timing rules, warning signs, and how to prevent life-threatening spinal hematomas.
Brand manufacturers create authorized generics-identical copies of their own drugs-to retain market share after patents expire. Learn how they're made, why they cost more than regular generics, and what this means for your prescriptions.
Learn how to verify if your medicine is real using official tools like EU FMD, FDA DSCSA, mobile apps, and barcode scanners. Protect yourself from counterfeit drugs with proven methods and expert-backed resources.
Learn the legal requirements for generic drug approval in the U.S. through the FDA's ANDA process, including bioequivalence standards, patent rules, manufacturing guidelines, and key challenges manufacturers face.
Medication reformulations change how drugs are made-not what’s in them. Learn why companies tweak formulas, how it affects your treatment, and what to do if your pill looks different.
Amiodarone, digoxin, and warfarin together create a deadly drug interaction that can cause toxic digoxin levels and life-threatening bleeding. Learn how to recognize the risks and what to do to stay safe.
Generic drugs work the same as brand-name medications but cost 80-85% less. Learn how they're made through reverse engineering, bioequivalence testing, and strict FDA manufacturing standards - without repeating clinical trials.